Highland Capital Management (Texas)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Highland Capital Management (Texas)’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$43.2M	Buy	1,592,979 +34,150	+2%	+$1.07M	2.53%	7
2019 Q1	$54.1M	Sell	1,558,829 -23,300	-1%	-$672K	3.37%	5
2018 Q4	$30.9M	Buy	1,582,129 +407,574	+35%	+$8.38M	2.37%	7
2018 Q3	$31.3M	Buy	1,174,555 +474,735	+68%	+$15.5M	1.73%	10
2018 Q2	$26.4M	Buy	699,820 +322,907	+86%	+$12.4M	1.5%	12
2018 Q1	$12.3M	Sell	376,913 -67,600	-15%	-$2.97M	0.63%	38
2017 Q4	$21.6M	Buy	444,513 +42,390	+11%	+$2.14M	0.99%	23
2017 Q3	$21.7M	Buy	402,123 +382,123	+1,911%	+$22.4M	0.96%	21
2017 Q2	$1.12M	Sell	20,000 -31,900	-61%	-$1.28M	0.05%	164
2017 Q1	$2.03M	Sell	51,900 -5,000	-9%	-$159K	0.1%	157
2016 Q4	$1.28M	Buy	56,900 +16,700	+42%	+$326K	0.06%	157
2016 Q3	$913K	Buy	+40,200	New	+$944K	0.03%	192
2016 Q2	–	Sell	-160,900	Closed	-$3.28M	–	286
2016 Q1	$3.28M	Sell	160,900 -131,990	-45%	-$4.19M	0.14%	138
2015 Q4	$15.1M	Sell	292,890 -44,110	-13%	-$2.14M	0.48%	63
2015 Q3	$14.4M	Sell	337,000 -114,791	-25%	-$5.54M	0.42%	66
2015 Q2	$20.6M	Buy	451,791 +356,599	+375%	+$14.3M	0.42%	60
2015 Q1	$3.61M	Buy	95,192 +45,392	+91%	+$1.56M	0.07%	161
2014 Q4	$1.41M	Buy	+49,800	New	+$1.38M	0.05%	148
2014 Q1	–	Sell	-8,834	Closed	-$227K	–	257
2013 Q4	$227K	Buy	+8,834	New	+$215K	0.01%	174

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Highland Capital Management (Texas)'s PTLA Position: Q2 2019 in Review

Highland Capital Management (Texas) increased its Portola Pharmaceuticals, Inc. (PTLA) stake by 2.2% in Q2 2019, buying an estimated $1.07M and bringing the position to 1,592,979 shares worth $43.2M. The position accounts for 2.53% of the portfolio, ranked #7.

Highland Capital Management (Texas) first reported a position in PTLA in Q4 2013 and has held it in 19 quarters since. The position peaked at $54.1M in Q1 2019. 202 funds tracked by Wall St. Rank hold PTLA as of Q2 2019.

Highland Capital Management (Texas) held 1,592,979 shares of Portola Pharmaceuticals, Inc. worth $43.2M as of Q2 2019.
Highland Capital Management (Texas) bought 34,150 Portola Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1.07M.
Portola Pharmaceuticals, Inc. made up 2.53% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #7 holding.
Highland Capital Management (Texas) first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and has held it in 19 quarters since.
Highland Capital Management (Texas)'s Portola Pharmaceuticals, Inc. position peaked at $54.1M in Q1 2019.
202 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.